ORCL director William G. Parrett sells 11,500 shares at $306
William G. Parrett, a director of Oracle Corporation (ORCL), reported a non-derivative transaction on 09/12/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
William G. Parrett, a director of Oracle Corporation (ORCL), reported a non-derivative transaction on 09/12/2025. The filing shows a sale of 11,500 shares of Oracle common stock at a reported price of $306 per share. Following the reported transactions, the form lists 17,764 shares held indirectly (by trust) and 9,311 shares held directly as the amounts beneficially owned after the transactions.
Positive
- None.
Negative
- Director sale disclosed: William G. Parrett sold 11,500 shares at $306 per share as reported on 09/12/2025
Insights
TL;DR: An Oracle director executed a single sizable sale of common stock; this disclosure is routine but relevant to monitoring insider activity.
From a trading-activity perspective, the Form 4 discloses a sale of 11,500 shares at $306 each by William G. Parrett and reports post-transaction beneficial ownership of 17,764 shares indirectly and 9,311 shares directly. The filing provides clear, specific quantities and price, enabling investors and compliance teams to update insider-holding records. The filing contains no derivative transactions and no other compensatory grants or purchases to contextualize the sale.
TL;DR: Insider sale disclosed by a director; disclosure meets Section 16 reporting requirements but shows no corporate governance red flags in isolation.
The Form 4 indicates the transaction was reported by an attorney-in-fact on behalf of William G. Parrett. The document lists the relationship as Director and specifies indirect ownership via a trust and direct holdings. There is no indication in the filing of any plan-based affirmative defense or related-party transaction beyond the standard reporting of sale and ownership. The disclosure is concise and follows required format.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 11,500 | $306.00 | $3.52M |
| Holding | Common Stock | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ORCL director William G. Parrett report on this Form 4?
Was the transaction in derivatives or non-derivative securities?
What is the reporting person’s relationship to Oracle (ORCL)?
Who signed the Form 4 on behalf of William G. Parrett?
AI-generated analysis. How Rhea-AI works. Not financial advice.